IL-12 INHIBITS APOPTOSIS INDUCED IN A HUMAN TH1 CLONE BY GP120/CD4 CROSS-LINKING AND CD3/TCR ACTIVATION OR BY IL-2 DEPRIVATION

被引:58
作者
RADRIZZANI, M
ACCORNERO, P
AMIDEI, A
AIELLO, A
DELIA, D
KURRLE, R
COLOMBO, MP
机构
[1] IST NAZL STUDIO & CURA TUMORI, I-20133 MILAN, ITALY
[2] BEHRINGWERKE AG, W-3550 MARBURG, GERMANY
关键词
D O I
10.1006/cimm.1995.1003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The aim of our work was to study apoptosis as a possible mechanism of CD4(+) lymphocyte depletion in AIDS patients and to test whether IL-12 could limit this phenomenon. As an in vitro model, we used a human IL-2-dependent Th1 clone from an uninfected individual. We found that CD4 cross-linking, obtained either by mouse anti-CD4 mAb plus goat anti-mouse or by recombinant gp120 plus anti-gp120 mAb, followed by activation with immobilized anti-CD3 or anti-TCR mAb, induced apoptosis at early times (15-25% apoptotic cells at 4 hr), whereas IL-2 deprivation required longer times (20-40 hr) to induce apoptosis. Both CD4 cross-linking and IL-2 deprivation-induced apoptosis appeared to be PTK-dependent and were inhibited by either IL-2 or IL-12. Our data suggest that in vivo CD4/gp120 interactions could directly prime the apoptosis of Th1 lymphocytes and that IL-2 and IL-12 could be used to prevent this phenomenon. (C) 1995 Academic Press, Inc.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 42 条
[1]   THE ADJUVANT EFFECT OF INTERLEUKIN-12 IN A VACCINE AGAINST LEISHMANIA-MAJOR [J].
AFONSO, LCC ;
SCHARTON, TM ;
VIEIRA, LQ ;
WYSOCKA, M ;
TRINCHIERI, G ;
SCOTT, P .
SCIENCE, 1994, 263 (5144) :235-237
[2]  
AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102
[3]   CROSS-LINKING CD4 BY HUMAN IMMUNODEFICIENCY VIRUS-GP120 PRIMES T-CELLS FOR ACTIVATION-INDUCED APOPTOSIS [J].
BANDA, NK ;
BERNIER, J ;
KURAHARA, DK ;
KURRLE, R ;
HAIGWOOD, N ;
SEKALY, RP ;
FINKEL, TH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1099-1106
[4]   BMA031, A MONOCLONAL-ANTIBODY SUITED TO IDENTIFY THE T-CELL RECEPTOR ALPHA-BETA/CD3 COMPLEX ON VIABLE HUMAN LYMPHOCYTES-T IN NORMAL AND DISEASE STATES [J].
BORST, J ;
VANDONGEN, JJM ;
DEVRIES, E ;
COMANSBITTER, WM ;
VANTOL, MJD ;
VOSSEN, JM ;
KURRLE, R .
HUMAN IMMUNOLOGY, 1990, 29 (03) :175-188
[5]  
BRUNDA MJ, 1994, J LEUKOCYTE BIOL, V55, P280
[6]   NATURAL-KILLER (NK) CELL STIMULATORY FACTOR INCREASES THE CYTOTOXIC ACTIVITY OF NK CELLS FROM BOTH HEALTHY DONORS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PATIENTS [J].
CHEHIMI, J ;
STARR, SE ;
FRANK, I ;
RENGARAJU, M ;
JACKSON, SJ ;
LLANES, C ;
KOBAYASHI, M ;
PERUSSIA, B ;
YOUNG, D ;
NICKBARG, E ;
WOLF, SF ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) :789-796
[7]   IMPAIRED INTERLEUKIN-12 PRODUCTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS [J].
CHEHIMI, J ;
STARR, SE ;
FRANK, I ;
DANDREA, A ;
MA, XJ ;
MACGREGOR, RR ;
SENNELIER, J ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1361-1366
[8]   RESTORATION OF HIV-SPECIFIC CELL-MEDIATED IMMUNE-RESPONSES BY INTERLEUKIN-12 IN-VITRO [J].
CLERICI, M ;
LUCEY, DR ;
BERZOFSKY, JA ;
PINTO, LA ;
WYNN, TA ;
BLATT, SP ;
DOLAN, MJ ;
HENDRIX, CW ;
WOLF, SF ;
SHEARER, GM .
SCIENCE, 1993, 262 (5140) :1721-1724
[9]   A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1993, 14 (03) :107-110
[10]   CHANGES IN INTERLEUKIN-2 AND INTERLEUKIN-4 PRODUCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE INDIVIDUALS [J].
CLERICI, M ;
HAKIM, FT ;
VENZON, DJ ;
BLATT, S ;
HENDRIX, CW ;
WYNN, TA ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :759-765